Sohaib Mir, Partner at LifeArc Ventures congratulates new portfolio company, GlycoEra, on their $130m fundraise

Date
May 28, 2025
Location
London

“Precision immunology represents a therapeutic area that is poised to deliver positive impact for patients suffering from a wide range of autoimmune diseases. GlycoEra’s team led by Ganesh Kaundinya is at the forefront of these efforts and we are pleased to support them in the development of a robust pipeline of precision immunology medicines”.